[Changes in weight and diabetes compensation (HbA(1c)) in patients with diabetes mellitus type 2 after adding exenatide (Byetta) to the current treatment in 28 diabetology departments in the Czech Republic - BIBY-I study (observations lasting 3 to 12 months)]

MLA

J, Perusicová, et al. “[Changes in Weight and Diabetes Compensation (HbA(1c)) in Patients with Diabetes Mellitus Type 2 after Adding Exenatide (Byetta) to the Current Treatment in 28 Diabetology Departments in the Czech Republic - BIBY-I Study (Observations Lasting 3 to 12 Months)].” Vnitrni Lekarstvi, vol. 59, no. 3, May 2013. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........f82448af0f06245762ade7f08fb628b5&authtype=sso&custid=ns315887.

APA

J, P., I, H., P, P., D, A., J, B., A, B., K, B., B, D., H, D., K, H., M, H., D, K., Z, K., G, M., H, M., K, O., M, P., L, R., E, R., … J, T. (2013). [Changes in weight and diabetes compensation (HbA(1c)) in patients with diabetes mellitus type 2 after adding exenatide (Byetta) to the current treatment in 28 diabetology departments in the Czech Republic - BIBY-I study (observations lasting 3 to 12 months)]. Vnitrni Lekarstvi, 59(3).

Chicago

J, Perusicová, Haladová I, Pit’hová P, Acsová D, Belobrádková J, Belzová A, Berková K, et al. 2013. “[Changes in Weight and Diabetes Compensation (HbA(1c)) in Patients with Diabetes Mellitus Type 2 after Adding Exenatide (Byetta) to the Current Treatment in 28 Diabetology Departments in the Czech Republic - BIBY-I Study (Observations Lasting 3 to 12 Months)].” Vnitrni Lekarstvi 59 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........f82448af0f06245762ade7f08fb628b5&authtype=sso&custid=ns315887.